top | item 28945888 Booster dose of Pfizer vaccine shows 95.6% efficacy in Phase 3 trial 2 points| dbroockman | 4 years ago |cnn.com | reply 1 comment order hn newest [+] [-] dbroockman|4 years ago|reply And that’s 95.6% efficacy relative to two shots! Relative to no shots it must be like 97%. Wow.
[+] [-] dbroockman|4 years ago|reply And that’s 95.6% efficacy relative to two shots! Relative to no shots it must be like 97%. Wow.
[+] [-] dbroockman|4 years ago|reply